Michael Ploug

Michael Ploug

Group leader

ORCID: 0000-0003-2215-4265

Publication year:
All
61 - 70 out of 171Page size: 10
  1. 2008

  2. Structure and inhibition of the urokinase-type plasminogen activator receptor(uPAR)

    Jacobsen, B., Kjaergaard, M., Gårdsvoll, H. & Ploug, Michael, 2008, The Cancer Degradome: Proteases and Cancer Biology. Edwards, D., Høyer-Hansen, G., Blasi, F. & Sloane, B. L. (eds.). Springer Verlag, p. 699-719

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

  3. Published

    Structure and ligand interactions of the urokinase receptor (uPAR)

    Kjærgaard, M., Hansen, L. V., Jacobsen, B., Gårdsvoll, H. & Ploug, Michael, 2008, In: Frontiers in Bioscience. 13, p. 5441-5461 21 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    The urokinase receptor and its structural homologue C4.4A in human cancer: expression, prognosis and pharmacological inhibition

    Jacobsen, B. & Ploug, Michael, 2008, In: Current Medicinal Chemistry. 15, 25, p. 2559-73 15 p.

    Research output: Contribution to journal › Review › Research › peer-review

  5. Published

    Altered expression of the urokinase receptor homologue, C4.4A, in invasive areas of human esophageal squamous cell carcinoma

    Hansen, L. V., Laerum, O. D., Illemann, M., Nielsen, B. S. & Ploug, Michael, 15 Feb 2008, In: International Journal of Cancer. Supplement. 122, 4, p. 734-41 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    A composite role of vitronectin and urokinase in the modulation of cell morphology upon expression of the urokinase receptor

    Hillig, T., Engelholm, Lars Henning, Ingvarsen, S., Madsen, Daniel Hargbøl, Gårdsvoll, Henrik, Larsen, J. K., Ploug, Michael, Danø, K., Kjøller, L. & Behrendt, Niels, 30 May 2008, In: Journal of Biological Chemistry. 283, 22, p. 15217-15223 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Imaging of urokinase-type plasminogen activator receptor expression using a 64Cu-labeled linear peptide antagonist by microPET

    Li, Z., Niu, G., Wang, H., He, L., Yang, L., Ploug, Michael & Chen, X., 1 Aug 2008, In: Clinical Cancer Research. 14, 15, p. 4758-66 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. 2009
  9. Published

    Expression of C4.4A in precursor lesions of non-small cell lung cancer

    Jacobsen, B., Santoni Rugiu, Eric, Illemann, M., Laerum, O. D. & Ploug, Michael, 2009, In: Journal of Thoracic Oncology.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. PLAUR (Plasminogen activator, urokinase receptor

    Jacobsen, B., Illemann, M. & Ploug, Michael, 2009

    Research output: Other contribution › Net publication - Internet publication › Research › peer-review

  11. Published

    Interactions of plasminogen activator inhibitor-1 with vitronectin involve an extensive binding surface and induce mutual conformational rearrangements

    Blouse, G. E., Dupont, D. M., Schar, C. R., Jensen, J. K., Minor, K. H., Anagli, J. Y., Gårdsvoll, Henrik, Ploug, Michael, Peterson, C. B. & Andreasen, P. A., 3 Mar 2009, In: Biochemistry. 48, 8, p. 1723-35 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Specific recognition of the C-terminal end of A beta 42 by a high affinity monoclonal antibody

    Axelsen, T. V., Holm, A., Birkelund, S., Christiansen, G., Ploug, Michael & Holm, I. E., Jul 2009, In: Molecular Immunology. 46, 11-12, p. 2267-73 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...3 4 5 6 7 8 9 10 ...18 Next

ID: 33978213